Access to Healthcare Improves Health Outcomes for Vulnerable Youth in Foster Care

In an era when the importance of comprehensive healthcare is more apparent than ever, the attention has started shifting towards the most vulnerable communities. Amidst this, the role of foster care in providing essential care and improving health outcomes for young individuals who cannot cater to their own needs has taken center stage. According to Child Welfare, there are currently over 391,000 children in the foster care system, emphasizing the magnitude of this issue.

What role does foster care play in the overall healthcare landscape, and how does it contribute to enhanced health outcomes? This core question guides the conversation in the latest episode of the Highway to Health podcast series, hosted by David Kemp.

In this episode, Kemp welcomed Teresa Stivers, the CEO of Walden Family Services, to discuss the intricate dynamics of foster care and the ways it can lead to better healthcare access, experiences, and outcomes for young people. The topics covered in this enlightening conversation include:

  • The essential role of foster care in providing care and resources for young individuals who cannot cater to their own needs
  • The personal journey of Teresa Stivers, her health scare, and the subsequent lifestyle changes
  • A deep dive into Walden Family Services, its vision, mission, and the range of services provided

Teresa Stivers, an expert in the field of foster care services, has led Walden Family Services with a burning passion for the welfare of women and children. Her personal experiences with her own children’s health issues have shaped her approach to caring for foster children, particularly those with special healthcare needs.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…